scispace - formally typeset
Journal ArticleDOI

Distinct Sets of Genetic Alterations in Melanoma

TLDR
The genetic alterations identified in melanoma at different sites and with different levels of sun exposure indicate that there are distinct genetic pathways in the development of melanoma and implicate CDK4 and CCND1 as independent oncogenes in melanomas without mutations in BRAF or N-RAS.
Abstract
Background Exposure to ultraviolet light is a major causative factor in melanoma, although the relationship between risk and exposure is complex. We hypothesized that the clinical heterogeneity is explained by genetically distinct types of melanoma with different susceptibility to ultraviolet light. Methods We compared genome-wide alterations in the number of copies of DNA and mutational status of BRAF and N-RAS in 126 melanomas from four groups in which the degree of exposure to ultraviolet light differs: 30 melanomas from skin with chronic sun-induced damage and 40 melanomas from skin without such damage; 36 melanomas from palms, soles, and subungual (acral) sites; and 20 mucosal melanomas. Results We found significant differences in the frequencies of regional changes in the number of copies of DNA and mutation frequencies in BRAF among the four groups of melanomas. Samples could be correctly classified into the four groups with 70 percent accuracy on the basis of the changes in the number of copies of...

read more

Citations
More filters
Journal ArticleDOI

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A

TL;DR: In this paper, the authors investigated the clinical and histologic characteristics of cutaneous malignant melanomas (CMM) in CDKN2A-mutated families and found that patients with p16-Leiden had significantly more superficial spreading, and less nodular and lentiginous melanomas.
Journal ArticleDOI

Molecular Pathways: Response and Resistance to BRAF and MEK Inhibitors in BRAF(V600E) Tumors

TL;DR: It is disappointing that cures are relatively rare, but this should not detract from the value of these agents to patients with cancer and the opportunity they provide in allowing us to gain a deeper understanding of drug response and resistance.
Journal ArticleDOI

microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.

TL;DR: Results support miR-211 as a leading miRNA candidate for melanoma diagnosis and miRNA in situ hybridization as a uniquely uncomplicated ancillary test.
Journal ArticleDOI

Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma.

TL;DR: This review focuses on the critical roles that melanoma exosomes play in the progression of this deadly disease, including the induction of migration, invasion, primary niche manipulation, immune modulation and pre-metastatic niche formation.
Journal ArticleDOI

Towards new therapeutic approaches for malignant melanoma.

TL;DR: It is apparent that using single agents targeting solely individual melanoma pathways might be insufficient for long-term survival, however, the outstanding results on melanoma survival observed with novel selective inhibitors of B-RAF, such as PLX4032 give hope that melanoma can be cured.
References
More filters
Journal ArticleDOI

R: A Language for Data Analysis and Graphics

TL;DR: In this article, the authors discuss their experience designing and implementing a statistical computing language, which combines what they felt were useful features from two existing computer languages, and they feel that the new language provides advantages in the areas of portability, computational efficiency, memory management, and scope.
Journal ArticleDOI

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

TL;DR: P16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein, and inhibits the catalytic activity of theCDK4/cyclin D enzymes.
Journal ArticleDOI

Comparison of discrimination methods for the classification of tumors using gene expression data

TL;DR: Different discrimination methods for the classification of tumors based on gene expression data include nearest-neighbor classifiers, linear discriminant analysis, and classification trees, which are applied to datasets from three recently published cancer gene expression studies.
Related Papers (5)